Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agile Therapeutics, Inc. - Common Stock (NQ: AGRX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Agile Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
AGRX Stock Earnings: Agile Therapeutics Misses EPS, Misses Revenue for Q4 2023
AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Agile Therapeutics: Q4 Earnings Insights
Via Benzinga
Agile Therapeutics's Earnings: A Preview
Via Benzinga
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Agile Therapeutics shares are trading lower by 61% during Tuesday's session. The company announced the suspension of its trading on the Nasdaq effective Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Agile Therapeutics's Earnings: A Preview
Via Benzinga
Why Shares of Agile Therapeutics Jumped This Week
The women's healthcare company got an analyst upgrade. 
Via The Motley Fool
Earnings Scheduled For March 22, 2024
Companies Reporting Before The Bell • Agile Therapeutics (NASDAQ:AGRX) is likely to report quarterly loss at $0.54 per share on revenue of $9.20 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Etsy, Inc. 
Via Benzinga
What's Going On With Women Health Focused Agile Therapeutics Stock Today?
Agile Therapeutics stock rises on premarket trading, exercising warrants for $4.8M gross proceeds with reduced exercise price of $1.25 per share. 
Via Benzinga
Why Is Bel Fuse (BELFB) Stock Down 17% Today?
Bel Fuse stock is falling on Thursday as investors in BELFB shares react to the company's lackluster Q4 2023 earnings report. 
Via InvestorPlace
Why Is Draganfly (DPRO) Stock Down 48% Today?
Draganfly stock is down on Thursday after the company announced details for a $3.6 million public offering of DPRO shares. 
Via InvestorPlace
Why Is BuzzFeed (BZFD) Stock Up 101% Today?
BuzzFeed stock is rising higher on Thursday as investors in BZFD react to it selling Complex for $108.6 million in cash. 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Is Agile Therapeutics (AGRX) Stock Up 87% Today?
Agile Therapeutics stock is rising higher on Thursday with heavy trading of AGRX shares despite a lack of news from the company. 
Via InvestorPlace
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Shares of NVIDIA Corporation (NASDAQ: NVDA) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong revenue... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday and we're starting the day with a breakdown of all the latest news this morning! 
Via InvestorPlace
5 Value Stocks In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
Agile Therapeutics, Inc. (NASDAQ: AGRX), the commercial-stage women’s healthcare company, posted a 122% increase in third-quarter revenue year-over-year, driven by strong demand for TwirlaⓇ... 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Agile Therapeutics (NASDAQ: AGRX) Upgraded To "Buy" Rating By Analysts At Maxim Group
Maxim Group, a major investment bank, conducts and publishes stock analysis through its Equity Research team. The team has a strong reputation in the industry; a host of major firms use its research.... 
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Agile Says It's On Track To Hit $25-$30 Million Net Annual Revenue After A Strong Performance In Its Second Quarter
On August 9, Agile Therapeutics (NASDAQ: AGRX) released its second-quarter financial results, showing significant growth in revenue from its innovative weekly bi 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Privacy Policy  |  Terms of Use  |  MNG Corporate Site Map  |  Copyright